These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 7758871)

  • 1. Aminoguanidine does not inhibit the initial phase of experimental diabetic retinopathy in rats.
    Hammes HP; Ali SS; Uhlmann M; Weiss A; Federlin K; Geisen K; Brownlee M
    Diabetologia; 1995 Mar; 38(3):269-73. PubMed ID: 7758871
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Secondary intervention with aminoguanidine retards the progression of diabetic retinopathy in the rat model.
    Hammes HP; Strödter D; Weiss A; Bretzel RG; Federlin K; Brownlee M
    Diabetologia; 1995 Jun; 38(6):656-60. PubMed ID: 7672485
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aminoguanidine inhibits the development of accelerated diabetic retinopathy in the spontaneous hypertensive rat.
    Hammes HP; Brownlee M; Edelstein D; Saleck M; Martin S; Federlin K
    Diabetologia; 1994 Jan; 37(1):32-5. PubMed ID: 8150227
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of inhibition of glycation and oxidative stress on the development of cataract and retinal vessel abnormalities in diabetic rats.
    Agardh E; Hultberg B; Agardh C
    Curr Eye Res; 2000 Jul; 21(1):543-9. PubMed ID: 11035534
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of advanced glycation end-products protects against retinal capillary basement membrane expansion during long-term diabetes.
    Gardiner TA; Anderson HR; Stitt AW
    J Pathol; 2003 Oct; 201(2):328-33. PubMed ID: 14517851
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aminoguanidine treatment inhibits the development of experimental diabetic retinopathy.
    Hammes HP; Martin S; Federlin K; Geisen K; Brownlee M
    Proc Natl Acad Sci U S A; 1991 Dec; 88(24):11555-8. PubMed ID: 1763069
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Depletion of nitric oxide synthase-containing neurons in the diabetic retina: reversal by aminoguanidine.
    Roufail E; Soulis T; Boel E; Cooper ME; Rees S
    Diabetologia; 1998 Dec; 41(12):1419-25. PubMed ID: 9867208
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Discordant effects of guanidines on renal structure and function and on regional vascular dysfunction and collagen changes in diabetic rats.
    Nyengaard JR; Chang K; Berhorst S; Reiser KM; Williamson JR; Tilton RG
    Diabetes; 1997 Jan; 46(1):94-106. PubMed ID: 8971088
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acceleration of experimental diabetic retinopathy in the rat by omega-3 fatty acids.
    Hammes HP; Weiss A; Führer D; Krämer HJ; Papavassilis C; Grimminger F
    Diabetologia; 1996 Mar; 39(3):251-5. PubMed ID: 8721768
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effects of aminoguanidine on retinopathy in STZ-induced diabetic rats.
    Luo D; Fan Y; Xu X
    Bioorg Med Chem Lett; 2012 Jul; 22(13):4386-90. PubMed ID: 22627042
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Response of capillary cell death to aminoguanidine predicts the development of retinopathy: comparison of diabetes and galactosemia.
    Kern TS; Tang J; Mizutani M; Kowluru RA; Nagaraj RH; Romeo G; Podesta F; Lorenzi M
    Invest Ophthalmol Vis Sci; 2000 Nov; 41(12):3972-8. PubMed ID: 11053301
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antioxidant treatment of experimental diabetic retinopathy in rats with nicanartine.
    Hammes HP; Bartmann A; Engel L; Wülfroth P
    Diabetologia; 1997 Jun; 40(6):629-34. PubMed ID: 9222640
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Calcium dobesilate attenuates vascular injury and the progression of diabetic retinopathy in streptozotocin-induced diabetic rats.
    Padilla E; Ganado P; Sanz M; Zeini M; Ruiz E; Triviño A; Ramírez AI; Salazar JJ; Ramírez JM; Rojas B; Hoz Rd; Tejerina T
    Diabetes Metab Res Rev; 2005; 21(2):132-42. PubMed ID: 15386814
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of R-(+)-alpha-lipoic acid on experimental diabetic retinopathy.
    Lin J; Bierhaus A; Bugert P; Dietrich N; Feng Y; Vom Hagen F; Nawroth P; Brownlee M; Hammes HP
    Diabetologia; 2006 May; 49(5):1089-96. PubMed ID: 16520919
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The relationship of glycaemic level to advanced glycation end-product (AGE) accumulation and retinal pathology in the spontaneous diabetic hamster.
    Hammes HP; Wellensiek B; Klöting I; Sickel E; Bretzel RG; Brownlee M
    Diabetologia; 1998 Feb; 41(2):165-70. PubMed ID: 9498649
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The BB Wistar rat: an experimental model for the study of diabetic retinopathy.
    Sima AA; Garcia-Salinas R; Basu PK
    Metabolism; 1983 Jul; 32(7 Suppl 1):136-40. PubMed ID: 6865763
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Captopril inhibits capillary degeneration in the early stages of diabetic retinopathy.
    Zhang JZ; Xi X; Gao L; Kern TS
    Curr Eye Res; 2007 Oct; 32(10):883-9. PubMed ID: 17963108
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacological inhibition of diabetic retinopathy: aminoguanidine and aspirin.
    Kern TS; Engerman RL
    Diabetes; 2001 Jul; 50(7):1636-42. PubMed ID: 11423486
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An aldose reductase inhibitor and aminoguanidine prevent vascular endothelial growth factor expression in rats with long-term galactosemia.
    Frank RN; Amin R; Kennedy A; Hohman TC
    Arch Ophthalmol; 1997 Aug; 115(8):1036-47. PubMed ID: 9258227
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Retinal capillary dilation: early diabetic-like retinopathy in the galactose-fed rat model.
    Glover JP; Jacot JL; Basso MD; Hohman TC; Robison WG
    J Ocul Pharmacol Ther; 2000 Apr; 16(2):167-72. PubMed ID: 10803427
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.